TG Therapeutics, Inc. (TGTX)
30.60
+0.17
(+0.56%)
USD |
NASDAQ |
Dec 10, 16:00
30.58
-0.02
(-0.08%)
After-Hours: 20:00
TG Therapeutics Market Cap: 4.858B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 169.83B |
| Karyopharm Therapeutics, Inc. | 110.49M |
| Axsome Therapeutics, Inc. | 7.525B |
| Krystal Biotech, Inc. | 6.951B |
| Arcutis Biotherapeutics, Inc. | 3.647B |
Market Cap Related Metrics
| PE Ratio | 11.01 |
| PS Ratio | 9.299 |
| Price to Book Value | 8.000 |
| Price | 30.60 |
| Earnings Yield | 9.08% |
| Operating PE Ratio | 48.13 |
| Normalized PE Ratio | 11.01 |